RE: Foralumab2 Jun 2020 10:19
Think I agree. I'm by no means a seasoned business strategist, but if the big ticket item is foralumab, then putting SPER in the shop window for a quick injection of funding does make a lot of sense. It almost feels like they stumbled upon SPER and want rid to concentrate on where they believe the real revenue is at.